About

Unlearn AI is a company based in California that creates and implements AI solutions to expedite clinical drug development and ultimately eradicate trial and error in healthcare.

Their technology emphasizes generative machine learning techniques to anticipate individual health results and model possible futures using patient digital twins.

These digital twins allow Unlearn AI to project how a patient's health might evolve over time, assess potential health outcomes, and evaluate comparative treatment effects.

The firm collaborates with pioneers in the pharmaceutical and biotech sectors to speed up clinical drug development and achieve full enrollment in AI-enhanced clinical trials more rapidly.

At present, Unlearn AI is constructing the leading AI enterprise in healthcare and is seeking innovative talent eager to shape the future of medicine.

The primary usage of Unlearn AI's technology lies in AI-driven clinical trials, where their digital twins can simulate 'what if?' scenarios to assess the potential health outcomes of various treatments with the goal of accelerating the

key features

use cases

Useful for

Price